<b>R</b>enal <b>A</b>thersosclerotic re<b>V</b>ascularization <b>E</b>valuation (RAVE Study): Study protocol of a randomized trial [NCT00127738]

• Main Authors: Pugash R, Perkins N, Atri M, Tobe Sheldon W, Bell Chaim M
• Format: Article
• Language: English
• Published: BMC 2007-01-01
• Series: BMC Nephrology
• Online Access: http://www.biomedcentral.com/1471-2369/8/4

<p>Abstract</p> <p>Background</p> <p>It is uncertain whether patients with renal vascular disease will have renal or mortality benefit from re-establishing renal blood flow with renal revascularization procedures. The RAVE study will compare renal revascularization to medical management for people with atherosclerotic renal vascular disease (ARVD) and the indication for revascularization. Patients will be assessed for the standard nephrology research outcomes of progression to doubling of creatinine, need for dialysis, and death, as well as other cardiovascular outcomes. We will also establish whether the use of a new inexpensive, simple and available ultrasound test, the renal resistance index (RRI), can identify patients with renal vascular disease who will not benefit from renal revascularization procedures<abbrgrp><abbr bid="B1">1</abbr></abbrgrp>.</p> <p>Methods/design</p> <p>This single center randomized, parallel group, pilot study comparing renal revascularization with medical therapy alone will help establish an infrastructure and test the feasibility of answering this important question in clinical nephrology. The main outcome will be a composite of death, dialysis and doubling of creatinine. Knowledge from this study will be used to better understand the natural history of patients diagnosed with renal vascular disease in anticipation of a Canadian multicenter trial. Data collected from this study will also inform the Canadian Hypertension Education Program (CHEP) Clinical Practice Guidelines for the management of Renal and Renal Vascular Disease. The expectation is that this program for ARVD, will enable community based programs to implement a comprehensive guidelines based diagnostic and treatment program, help create an evidence based approach for the management of patients with this condition, and possibly reduce or halt the progression of kidney disease in these patients.</p> <p>Discussion</p> <p>Results from this study will determine the feasibility of a multicentered study for the management of renovascular disease.</p>